These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10077229

  • 1. Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells.
    Sakamoto H, Hara H, Hirano K, Adachi T.
    Cancer Lett; 1999 Jan 08; 135(1):113-9. PubMed ID: 10077229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
    Benderra Z, Trussardi A, Morjani H, Villa AM, Doglia SM, Manfait M.
    Eur J Cancer; 2000 Feb 08; 36(3):428-34. PubMed ID: 10708946
    [Abstract] [Full Text] [Related]

  • 4. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.
    Paul S, Breuninger LM, Tew KD, Shen H, Kruh GD.
    Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):6929-34. PubMed ID: 8692921
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.
    Chuman Y, Chen ZS, Sumizawa T, Furukawa T, Haraguchi M, Takebayashi Y, Niwa K, Yamada K, Aikou T, Akiyama S.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):158-65. PubMed ID: 8806607
    [Abstract] [Full Text] [Related]

  • 6. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
    Grech KV, Davey RA, Davey MW.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1283-9. PubMed ID: 9719484
    [Abstract] [Full Text] [Related]

  • 7. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.
    Rappa G, Lorico A, Flavell RA, Sartorelli AC.
    Cancer Res; 1997 Dec 01; 57(23):5232-7. PubMed ID: 9393740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.
    Loe DW, Stewart RK, Massey TE, Deeley RG, Cole SP.
    Mol Pharmacol; 1997 Jun 01; 51(6):1034-41. PubMed ID: 9187270
    [Abstract] [Full Text] [Related]

  • 10. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.
    Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS.
    Cancer Res; 2001 Jul 15; 61(14):5461-7. PubMed ID: 11454692
    [Abstract] [Full Text] [Related]

  • 11. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.
    Gaj CL, Anyanwutaku I, Chang YH, Cheng YC.
    Biochem Pharmacol; 1998 Apr 15; 55(8):1199-211. PubMed ID: 9719474
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
    Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa T.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):859-63. PubMed ID: 9647783
    [Abstract] [Full Text] [Related]

  • 13. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function.
    Vanhoefer U, Yin MB, Harstrick A, Seeber S, Rustum YM.
    Biochem Pharmacol; 1997 Mar 21; 53(6):801-9. PubMed ID: 9113101
    [Abstract] [Full Text] [Related]

  • 14. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.
    Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D.
    Cancer Res; 1996 Mar 01; 56(5):988-94. PubMed ID: 8640791
    [Abstract] [Full Text] [Related]

  • 15. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
    Chen ZS, Aoki S, Komatsu M, Ueda K, Sumizawa T, Furukawa T, Okumura H, Ren XQ, Belinsky MG, Lee K, Kruh GD, Kobayashi M, Akiyama S.
    Int J Cancer; 2001 Jul 01; 93(1):107-13. PubMed ID: 11391629
    [Abstract] [Full Text] [Related]

  • 16. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
    Chen ZS, Furukawa T, Sumizawa T, Ono K, Ueda K, Seto K, Akiyama SI.
    Mol Pharmacol; 1999 May 01; 55(5):921-8. PubMed ID: 10220571
    [Abstract] [Full Text] [Related]

  • 17. Multidrug resistance-associated protein (MRP) mediated transport of daunomycin and leukotriene C4 (LTC4) in isolated plasma membrane vesicles.
    Ding GY, Shen T, Center MS.
    Anticancer Res; 1999 May 01; 19(4B):3243-8. PubMed ID: 10652618
    [Abstract] [Full Text] [Related]

  • 18. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells.
    Paul S, Breuninger LM, Kruh GD.
    Biochemistry; 1996 Nov 05; 35(44):14003-11. PubMed ID: 8909298
    [Abstract] [Full Text] [Related]

  • 19. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
    Chuman Y, Chen ZS, Seto K, Sumizawa T, Furukawa T, Tani A, Haraguchi M, Niwa K, Yamada K, Aikou T, Akiyama S.
    Cancer Lett; 1998 Jul 03; 129(1):69-76. PubMed ID: 9714337
    [Abstract] [Full Text] [Related]

  • 20. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells.
    Chen ZS, Mutoh M, Sumizawa T, Furukawa T, Haraguchi M, Tani A, Akiyama S.
    Biochem Biophys Res Commun; 1997 Jul 30; 236(3):586-90. PubMed ID: 9245693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.